Engineering Biology

Ursheet invests in the enterprise sector and co-leads Mayfield’s Engineering Biology investment practice.

His Mayfield investments include Mammoth Biosciences, Mission Bio, Qventus, Endpoint Health and unannounced companies in neuromodulation therapeutics and precision diagnostics for maternal and fetal health in Healthcare & Engineering Biology. His investments in the enterprise sector include Versa Networks, ShiftLeft, Rancher Labs (pending acquisition by SUSE), CloudGenix (acquired by Palo Alto Networks) and Netsil (acquired by Nutanix).

He is a proven repeat entrepreneur and executive at Cisco and Microsoft. Prior to joining Mayfield in 2013, he was a co-founder & CEO of StorSimple and then a GM at Microsoft. StorSimple was the leading cloud-integrated storage company that was acquired by Microsoft. StorSimple was the largest acquisition among the first generation of cloud IaaS/PaaS technology companies and has been highlighted by Microsoft as one of its most successful acquisitions. Ursheet holds an MBA from the Wharton School and a Bachelors in Computer Science from the Indian Institute of Technology in Mumbai, from which he received the Young Alumni Achiever award in 2015.

Arvind Gupta co-leads Mayfield’s Engineering Biology practice. He was the first investor in breakout bio companies such as Geltor, Synthex, Prime Roots, NotCo, Prellis, New Culture, DNA Lite and Memphis Meats.

As Founder of IndieBio, Arvind redefined the pace and possibilities of early stage biotech, investing in over 136 companies in five years, defining human and planetary health, and growing the IndieBio portfolio into billions of dollars in value. Under his leadership, IndieBio expanded to New York and grew to fifteen investment professionals with a world class adjunct partner board. He is now Venture Advisor at IndieBio.

Arvind is the author of Decoding the World: A Roadmap for the Questioner, published by Twelve Books, a division of the Hachette Publishing Group. He was honored with the F50 Global Award for Impact in HealthTech Innovation. He is a frequent speaker at TechCrunch Disrupt, Slush, TedX and Future FoodTech. His work has been profiled in global media outlets such as Bloomberg News, Forbes, The Guardian UK, Neo.life, Nikkei News, Rotman, The Times of India, and CGTN in China. Arvind has been a guest lecturer at UCSF, MIT and Harvard and is a judge at the annual BIO conference startup stadium.

Prior to founding IndieBio, Arvind was Design Director at IDEO in Shanghai where he earned numerous international design awards and presented his work at the San Francisco Museum of Modern Art.

Arvind received his B.S. in Genetic Engineering from UCSB. He holds 8 patents.

Arvind is married to an Icelander and has two daughters.

Top Five on Midas List 2020 »

Navin leads Mayfield. Under his leadership, Mayfield has raised over $2.2 billion in new capital through eight funds – (six US and two dedicated India funds); expanded the investing team with world-class professionals; and assembled a comprehensive team of portfolio services executives.

Navin has been named a Young Global Leader by the World Economic Forum and has ranked on the Forbes Midas List of Top 100 Tech Investors twelve times, including being named in the Top Five in 2020.

During his venture capital career, Navin has invested in over 50 companies, of which 17 have gone public and over 20 have been acquired. Navin was one of the earliest Silicon Valley investors to leverage the promise of tech in India.

As an entrepreneur, Navin has co-founded or led three startups including VXtreme: a streaming media platform, acquired by Microsoft to become Windows Media; Rivio/CPA.com: a SaaS provider for small businesses, and iBeam Broadcasting (NASDAQ:IBEM): a streaming media content delivery network. Navin holds an MS degree in electrical engineering from Stanford University and a B.Tech degree in electrical engineering from IIT Delhi, where he was honored with the distinguished IIT Alumni Award.

Tim invests in the consumer sector. Some of his current investments include Grove Collaborative, TRIPP, and Tonal. Tim’s venture capital experience includes leading investments at Norwest Venture Partners and Gabriel Venture Partners. His operational experience includes working in product management and engineering across Asia for Gateway, Inc. and General Motors.

Tim holds an MBA with honors from the Stanford Graduate School of Business, and a master’s and bachelor’s in Electrical Engineering/System Engineering from the University of Michigan.

Investing in Engineering Biology to transform human and planetary health.

Mayfield is investing at all stages of the Engineering Biology Innovation Loop

Non-obvious Insights from Healthcare Innovators

Investments

Some Current:

Stealth

Ursheet Parikh

Arvind Gupta

Navin Chaddha

Tim Chang